MedPath

The effect of ajwain, viper’s bugloss and cinnamon product on multiple sclerosis patients

Phase 3
Conditions
MULTIPLE SCLEROSIS.
Multiple sclerosis
Registration Number
IRCT20190120042424N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

proved MS disease according to clinical examination and patient history
EDSS score between 2-5.5
regular and fix drug therapy in last 4 week

Exclusion Criteria

drug or alcohol abuse history
pregnancy and lactation in last 12 months
kidney and liver dysfunction
steroid therapy 2 months before study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
iver function. Timepoint: study start, 3 months after taking drug. Method of measurement: laboratory exam.;Quality of life. Timepoint: study start, 3 months after taking drug. Method of measurement: MSQOL-54 questionaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath